- Intelligent Bio Solutions (NASDAQ: INBS) is expanding its APAC footprint with the deployment of its fingerprint drug testing system across over 20 sites of Managed Waste Service in New South Wales, Australia.
- This marks Managed Waste Service's initial roll-out of in-house drug testing, enhancing operational efficiency and safety.
- The non-invasive and quick drug testing solution by INBS is currently utilized by over 450 organizations globally.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) has announced a strategic partnership with Managed Waste Service (MWS), a leading waste management provider in Australia, to implement its Intelligent Fingerprinting Drug Screening System. The cutting-edge drug testing solution will be rolled out across more than 20 operational sites in New South Wales, marking MWS’s first venture into in-house drug testing.
The system allows for rapid, non-invasive drug screening through fingerprint sweat analysis, delivering results in under ten minutes. This advancement enables MWS to efficiently conduct pre-employment, random, and on-site testing, facilitating greater control over safety processes without relying on traditional outsourced models.
The technology's scalability is a significant factor, providing a portable solution that supports the nature of MWS's remote and fieldwork operations. This initiative is part of a broader strategy by INBS to expand its market presence within safety-critical industries, with the fingerprint drug testing system already in use by more than 450 organizations across 24 countries.
Con Constantinou, Partner at Managed Waste Service, emphasized the benefits of the new system, noting, "We operate across more than 20 sites and must ensure every team member is fit for work daily. INBS’s on-site testing solution provides the visibility and speed we need to stay compliant and keep teams safe."
As Intelligent Bio Solutions continues to transform workplace drug testing with this innovative method, the partnership with MWS underscores a growing shift towards on-site, efficient testing solutions. This aligns with the broader industry move towards innovative, scalable, and practical safety measures.
